| [1] |
Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast[J]. Nat Genet, 1996, 13(2): 175-182.
pmid: 8640223
|
| [2] |
Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy[J]. Orphanet J Rare Dis, 2008, 3: 26.
doi: 10.1186/1750-1172-3-26
pmid: 18817572
|
| [3] |
Lawlor MW, Dowling JJ. X-linked myotubular myopathy[J]. Neuromuscul Disord, 2021, 31(10): 1004-1012.
doi: 10.1016/j.nmd.2021.08.003
|
| [4] |
Beggs AH, Byrne BJ, De Chastonay S, et al. A multicenter, retrospective medical record review of X-linked myotubular myopathy: the recensus study[J]. Muscle Nerve, 2018, 57(4): 550-560.
doi: 10.1002/mus.26018
pmid: 29149770
|
| [5] |
Martin C, Servais L. X-linked myotubular myopathy: an untreated treatable disease[J]. Expert Opin Biol Ther, 2025, 25(4): 379-394.
doi: 10.1080/14712598.2025.2473430
|
| [6] |
Wang CH, Dowling JJ, North K, et al. Consensus statement on standard of care for congenital myopathies[J]. J Child Neurol, 2012, 27(3): 363-382.
doi: 10.1177/0883073812436605
pmid: 22431881
|
| [7] |
胡勇, 黄希. 新发突变基因的新生儿X-连锁肌小管肌病1例并文献回顾[J]. 中南大学学报(医学版), 2024, 49(3): 491-496.
|
|
Hu Y, Huang X. Neonatal X-linked myotubular myopathy with a de novo mutation: A case report and literature review[J]. Zhongnan Daxue Xuebao (Yixueban), 2024, 49(3): 491-496.
|
| [8] |
付杰, 徐承琴, 郑爱华, 等. MTM1基因半合子突变致新生儿X连锁中央核肌病1例[J]. 浙江医学, 2024, 46(22): 2433-2435.
|
|
Fu J, Xu CQ, Zheng AH, et al. A case of neonatal X-linked centronuclear myopathy caused by a hemizygous mutation in the MTM1 gene[J]. Zhejiang Yixue, 2024, 46(22): 2433-2435.
|
| [9] |
王钿钿, 王瑜, 王化彬. MTM1基因半合子突变及RYR1基因杂合突变致新生儿X-连锁肌管肌病2例临床分析[J]. 中华实用诊断与治疗杂志, 2023, 37(7): 722-726.
|
|
Wang TT, Wang Y, Wang HB. Clinical analysis of two cases of neonatal X-linked myotubular myopathy caused by hemizygous mutation of MTM1 gene and heterozygous mutation of RYR1 gene[J]. Zhonghua Shiyong Zhenduan Yu Zhiliao Zazhi, 2023, 37(7): 722-726.
|
| [10] |
洪先慧, 李海英, 吴尤佳. MTM1基因突变致新生儿肌管性肌病1例[J]. 儿科药学杂志, 2023, 29(2): 64-66.
|
|
Hong XH, Li HY, Wu YJ. A case of neonatal myotubular myopathy caused by MTM1 gene mutation[J]. Erke Yaoxue Zazhi, 2023, 29(2): 64-66.
|
| [11] |
谢添, 葛佳静, 张子明, 等. MTM1基因变异致5例新生儿中央核肌病的临床及遗传学分析[J]. 中国当代儿科杂志, 2025, 27(9): 1071-1075.
|
|
Xie T, Ge JJ, Zhang ZM, et al. Clinical and genetic features of 5 neonates with centronuclear myopathy caused by MTM1 gene variation[J]. Zhongguo Dangdai Erke Zazhi, 2025, 27(9): 1071-1075.
|
| [12] |
Dowling JJ, Lawlor MW, Das S. X-Linked Myotubular Myopathy. 2002 Feb 25 [updated 2018 Aug 23]. In: Adam MP, Bick S, Mirzaa GM, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025.
|
| [13] |
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020, 22(2): 245-257.
doi: 10.1038/s41436-019-0686-8
pmid: 31690835
|
| [14] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
doi: 10.1038/gim.2015.30
pmid: 25741868
|
| [15] |
Annoussamy M, Lilien C, Gidaro T, et al. X-linked myotubular myopathy: a prospective international natural history study[J]. Neurology, 2019, 92(16): e1852-e1867.
|
| [16] |
Amburgey K, Tsuchiya E, de Chastonay S, et al. A natural history study of X-linked myotubular myopathy[J]. Neurology, 2017, 89(13): 1355-1364.
doi: 10.1212/WNL.0000000000004415
pmid: 28842446
|
| [17] |
Darras BT, De Vivo DC. Precious SMA natural history data: a benchmark to measure future treatment successes[J]. Neurology, 2018, 91(8): 337-339.
doi: 10.1212/WNL.0000000000006026
pmid: 30045956
|
| [18] |
Bhattacharyya T, Ghosh A, Verma S, et al. Structural rationale to understand the effect of disease-associated mutations on Myotubularin[J]. Curr Res Struct Biol, 2023, 5: 100100.
|
| [19] |
McEntagart M, Parsons G, Buj-Bello A, et al. Genotype-phenotype correlations in X-linked myotubular myopathy[J]. Neuromuscul Disord, 2002, 12(10): 939-946.
doi: 10.1016/S0960-8966(02)00153-0
|
| [20] |
Fattori F, Maggi L, Bruno C, et al. Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort[J]. J Neurol, 2015, 262(7): 1728-1740.
doi: 10.1007/s00415-015-7757-9
pmid: 25957634
|
| [21] |
Shieh PB, Kuntz NL, Dowling JJ, et al. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial[J]. Lancet Neurol, 2023, 22(12): 1125-1139.
doi: 10.1016/S1474-4422(23)00313-7
pmid: 37977713
|
| [22] |
Lawlor MW, Schoser B, Margeta M, et al. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial[J]. EBioMedicine, 2024, 99: 104894.
doi: 10.1016/j.ebiom.2023.104894
|
| [23] |
Andreoletti G, Romano O, Chou HJ, et al. High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy[J]. Am J Hum Genet, 2023, 110(10): 1648-1660.
doi: 10.1016/j.ajhg.2023.08.008
pmid: 37673065
|
| [24] |
Voermans NC, Ferreiro A, Aartsema-Rus A, et al. Gene therapy for X-linked myotubular myopathy: the challenges[J]. Lancet Neurol, 2023, 22(12): 1089-1091.
doi: 10.1016/S1474-4422(23)00416-7
pmid: 37977700
|
| [25] |
Wilson JM, Flotte TR. Moving forward after two deaths in a gene therapy trial of myotubular myopathy[J]. Hum Gene Ther, 2020, 31(13-14): 695-696.
doi: 10.1089/hum.2020.182
pmid: 32605399
|
| [26] |
Ross LF, Clarke AJ. A historical and current review of newborn screening for neuromuscular disorders from around the world: lessons for the United States[J]. Pediatr Neurol, 2017, 77: 12-22.
doi: S0887-8994(16)30965-1
pmid: 29079012
|
| [27] |
Dangouloff T, Boemer F, Servais L. Newborn screening of neuromuscular diseases[J]. Neuromuscul Disord, 2021, 31(10): 1070-1080.
doi: 10.1016/j.nmd.2021.07.008
|
| [28] |
Dangouloff T, Lang H, Benmhammed N, et al. Newborn screening and rapid genomic diagnosis of neuromuscular diseases[J]. J Neuromuscul Dis, 2025, 12(2): 157-172.
|
| [29] |
Tanner SM, Laporte J, Guiraud-Chaumeil C, et al. Confirmation of prenatal diagnosis results of X-linked recessive myotubular myopathy by mutational screening, and description of three new mutations in the MTM1 gene[J]. Hum Mutat, 1998, 11(1): 62-68.
pmid: 9450905
|
| [30] |
De Rycke M, Berckmoes V. Preimplantation genetic testing for monogenic disorders[J]. Genes (Basel), 2020, 11(8): 871.
doi: 10.3390/genes11080871
|
| [31] |
Luglio A, Maggi E, Riviello FN, et al. Hereditary neuromuscular disorders in reproductive medicine[J]. Genes (Basel), 2024, 15(11): 1409.
doi: 10.3390/genes15111409
|